Related Experiment Video
Updated: Jan 17, 2026

06:16
Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
3.0K
FACTORS INFLUENCING THE DELAYED DIAGNOSIS OF STARGARDT DISEASE AND IMPACT ON THERAPEUTIC OPPORTUNITIES
Angela S Li1, Paula Morales Moreno, Cesar Estrada Puente
1Department of Ophthalmology, Duke University, Durham, North Carolina.
Retina (Philadelphia, Pa.)
|September 23, 2025
Summary
Patients with Stargardt Disease (STGD) experience significant delays in diagnosis, leading to vision loss. Understanding factors like age of onset can help streamline care for this inherited retinal disease.
Area of Science:
- Ophthalmology
- Genetics
- Medical Diagnostics
Background:
- Stargardt Disease (STGD) is a common inherited retinal disease causing progressive vision loss.
- The variability in STGD phenotypes and initial symptoms can complicate early diagnosis.
Purpose of the Study:
- To analyze the diagnostic delay in Stargardt Disease (STGD) based on age of onset.
- To identify factors contributing to the prolonged time from symptom onset to molecular diagnosis.
Main Methods:
- Retrospective chart review of 87 patients with molecularly confirmed STGD.
- Analysis of time intervals from symptom onset to initial sub-specialist and inherited retinal disease (IRD) specialist visits.
Main Results:
- The average delay from symptom onset to an IRD specialist was over 10 years.
- Intermediate-onset STGD showed significantly longer diagnostic delays compared to early and late-onset forms.
- Visual acuity declined significantly during the diagnostic delay period.
Conclusions:
- Long diagnostic delays in STGD contribute to irreversible vision loss and missed clinical trial opportunities.
- Factors influencing delay include age of onset, initial symptoms, and care transitions.
- Multimodal screening, streamlined referrals, and increased awareness are crucial to mitigate diagnostic delays.
Related Concept Videos
Photoreceptors and Visual Pathways
8.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.8K
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963

